Does TERAZOSIN Cause Product use issue? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Product use issue have been filed in association with TERAZOSIN (terazosin). This represents 5.5% of all adverse event reports for TERAZOSIN.
29
Reports of Product use issue with TERAZOSIN
5.5%
of all TERAZOSIN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product use issue From TERAZOSIN?
Of the 29 reports, 10 (34.5%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Therapeutic product effect incomplete (75)
Asthma (66)
Dyspnoea (60)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which TERAZOSIN Alternatives Have Lower Product use issue Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE